Report cover image

US Flavors and Fragrances Market Size, Share, Trends, Industry Analysis Report: By Product (Natural and Aroma Chemicals) and By Application – Market Forecast, 2025–2034

Publisher Polaris Market Research & Consulting LLP
Published May 01, 2025
Length 126 Pages
SKU # PLRS20199223

Description

The US flavors and fragrances market size is expected to reach USD 8.43 billion by 2034, according to a new study by Polaris Market Research. The report “US Flavors and Fragrances Market Size, Share, Trends, Industry Analysis Report: By Product (Natural and Aroma Chemicals) and By Application – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market encompasses the formulation, production, and application of compounds that enhance the sensory attributes of consumables and personal care products. This market plays a pivotal role in product differentiation and consumer brand engagement across sectors, including food and beverages, cosmetics, pharmaceuticals, and home care. A notable driver of market growth is the escalating demand for clean-label and wellness-focused formulations, where botanical extracts, fermentation-derived ingredients, and essential oils are replacing synthetic counterparts. Heightened consumer awareness and regulatory pressure around ingredient transparency are compelling manufacturers to invest in natural, traceable, and sustainably sourced raw materials. Advancements in biotechnology, precision fermentation, and green chemistry are also supporting the development of novel compounds, expanding both technical capabilities and product portfolios.

Trends such as sensory branding, mood-enhancing aromas, and multisensory consumption are reinforcing US flavors and fragrances market demand, particularly in premium and niche applications. The increasing convergence of wellness and luxury in personal care and food categories is opening new opportunities for customized scent and flavor experiences. Moreover, innovation in encapsulation, controlled release, and AI-enabled flavor modeling is enabling manufacturers to deliver more consistent, high-performance outcomes. Strategic investments in R&D, formulation platforms, and sustainable sourcing strategies are fueling market expansion, as companies respond to evolving consumer preferences and competitive differentiation imperatives. The market is becoming more innovation-centric, value-driven, and responsive to shifts in lifestyle and consumption patterns, positioning it for resilient long-term growth.

US Flavors and Fragrances Market Report Highlights

Based on product, the US flavors and fragrances market is segmented into natural and aroma chemicals. The natural segment accounted for a larger market share in 2024 due to the surge in demand for botanical and organic inputs across food, beverage, and personal care applications.

In terms of application, the market is segmented into flavors and fragrances. The flavors segment held a larger market share in 2024 due to the ongoing expansion of the processed food and functional beverage sectors.

Alpha Aromatics; Archer-Daniels-Midland Company; BASF SE; dōTERRA International; Elevance Renewable Sciences, Inc.; International Flavors & Fragrances Inc.; Ungerer & Company; Vigon International, Inc.; and Young Living Essential Oils are a few key market players.

Polaris Market Research has segmented the market report on the basis of product and application:

By Product Outlook (Revenue, USD Billion, 2020–2034)

Natural

Essential Oils

Oleoresins

Others

Aroma Chemicals

By Application Outlook (Revenue, USD Billion, 2020–2034)

Flavors

Fragrances

Table of Contents

126 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Device Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. US Cardiovascular Device Market Insights
4.1. US Cardiovascular Device Market – Market Snapshot
4.2. US Cardiovascular Device Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Aging Population and Increased Surgical Interventions
4.2.1.2. Increasing Awareness and Preventive Screenings
4.2.2. Restraints and Challenges
4.2.2.1. High Cost of the Devices
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. US Cardiovascular Device Market Trends
4.6. Value Chain Analysis
5. US Cardiovascular Device Market, by Device Type
5.1. Key Findings
5.2. Introduction
5.2.1. US Cardiovascular Device Market, by Device Type, 2020-2034 (USD billion)
5.3. Diagnostic And Monitoring Devices
5.3.1. US Cardiovascular Device Market, by Diagnostic and Monitoring Devices, 2020-2034 (USD billion)
5.3.2. Electrocardiogram
5.3.2.1. US Cardiovascular Device Market, by Electrocardiogram, 2020-2034 (USD billion)
5.3.3. Remote Cardiac Monitoring
5.3.3.1. US Cardiovascular Device Market, by Remote Cardiac Monitoring, 2020-2034 (USD billion)
5.3.4. MRI
5.3.4.1. US Cardiovascular Device Market, by MRI, 2020-2034 (USD billion)
5.3.5. Others
5.3.5.1. US Cardiovascular Device Market, by Others, 2020-2034 (USD billion)
5.4. Therapeutic And Surgical Devices
5.4.1.1. US Cardiovascular Device Market, by Therapeutic and Surgical Devices, 2020-2034 (USD billion)
5.4.2. Ventricular Assist Devices
5.4.2.1. US Cardiovascular Device Market, by Ventricular Assist Devices, 2020-2034 (USD billion)
5.4.3. Cardiac Rhythm Management Devices
5.4.3.1. US Cardiovascular Device Market, by Cardiac Rhythm Management Devices, 2020-2034 (USD billion)
5.4.4. Catheter
5.4.4.1. US Cardiovascular Device Market, by Catheter, 2020-2034 (USD billion)
5.4.5. Stents
5.4.5.1. US Cardiovascular Device Market, by Stents, 2020-2034 (USD billion)
5.4.6. Others
5.4.6.1. US Cardiovascular Device Market, by Others, 2020-2034 (USD billion)
6. US Cardiovascular Device Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. US Cardiovascular Device Market, by Application, 2020-2034 (USD billion)
6.3. Heart Failure
6.3.1. US Cardiovascular Device Market, by Heart Failure, 2020-2034 (USD billion)
6.4. Cardiac Arrhythmia
6.4.1. US Cardiovascular Device Market, by Cardiac Arrhythmia, 2020-2034 (USD billion)
6.5. Coronary Artery Disease
6.5.1. US Cardiovascular Device Market, by Steel Plate, 2020-2034 (USD billion)
6.6. Others
6.6.1. US Cardiovascular Device Market, by Others, 2020-2034 (USD billion)
7. US Cardiovascular Device Market, by End Use
7.1. Key Findings
7.2. Introduction
7.2.1. US Cardiovascular Device Market, by End Use, 2020-2034 (USD billion)
7.3. Hospitals
7.3.1. US Cardiovascular Device Market, by Hospitals, 2020-2034 (USD billion)
7.4. Ambulatory Surgical Centers
7.4.1. US Cardiovascular Device Market, by Ambulatory Surgical Centers, 2020-2034 (USD billion)
7.5. Specialty Clinics
7.5.1. US Cardiovascular Device Market, by Specialty Clinics, 2020-2034 (USD billion)
8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Development
9.2. B. Braun Melsungen AG
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Development
9.3. Biotronik SE & Co.KG
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Development
9.4. Boston Scientific Corporation
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Development
9.5. C. R. Bard, Inc.
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Development
9.6. Cook Medicals
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Development
9.7. Lepu Medicals
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Development
9.8. Liaoning Biomedical Materials
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Recent Development
9.9. Medtronic Plc
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Recent Development
9.10. Meril Life Sciences
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Recent Development
9.11. MicroPort Scientific Corporation
9.11.1. Company Overview
9.11.2. Financial Performance
9.11.3. Product Benchmarking
9.11.4. Recent Development
9.12. Terumo Corporation
9.12.1. Company Overview
9.12.2. Financial Performance
9.12.3. Product Benchmarking
9.12.4. Recent Development
9.13. Translumina GmbH
9.13.1. Company Overview
9.13.2. Financial Performance
9.13.3. Product Benchmarking
9.13.4. Recent Development
9.14. Vascular Concepts
9.14.1. Company Overview
9.14.2. Financial Performance
9.14.3. Product Benchmarking
9.14.4. Recent Development
9.15. Jude Medical, Inc.
9.15.1. Company Overview
9.15.2. Financial Performance
9.15.3. Product Benchmarking
9.15.4. Recent Development
9.16. Edward lifesciences corporation
9.16.1. Company Overview
9.16.2. Financial Performance
9.16.3. Product Benchmarking
9.16.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us